101
|
Lymphocyte Fate and Metabolism: A Clonal Balancing Act. Trends Cell Biol 2017; 27:946-954. [PMID: 28818395 DOI: 10.1016/j.tcb.2017.07.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2017] [Revised: 07/12/2017] [Accepted: 07/24/2017] [Indexed: 01/16/2023]
Abstract
Activated lymphocytes perform a clonal balancing act, yielding a daughter cell that differentiates owing to intense PI3K signaling, alongside a self-renewing sibling cell with blunted anabolic signaling. Divergent cellular anabolism versus catabolism is emerging as a feature of several developmental and regenerative paradigms. Metabolism can dictate cell fate, in part, because lineage-specific regulators are embedded in the circuitry of conserved metabolic switches. Unequal transmission of PI3K signaling during regenerative divisions is reminiscent of compartmentalized PI3K activity during directed motility or polarized information flow in non-dividing cells. The diverse roles of PI3K pathways in membrane traffic, cell polarity, metabolism, and gene expression may have converged to instruct sibling cell feast and famine, thereby enabling clonal differentiation alongside self-renewal.
Collapse
|
102
|
Gullicksrud JA, Li F, Xing S, Zeng Z, Peng W, Badovinac VP, Harty JT, Xue HH. Differential Requirements for Tcf1 Long Isoforms in CD8 + and CD4 + T Cell Responses to Acute Viral Infection. THE JOURNAL OF IMMUNOLOGY 2017; 199:911-919. [PMID: 28652395 DOI: 10.4049/jimmunol.1700595] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/06/2017] [Accepted: 06/07/2017] [Indexed: 12/11/2022]
Abstract
In response to acute viral infection, activated naive T cells give rise to effector T cells that clear the pathogen and memory T cells that persist long-term and provide heightened protection. T cell factor 1 (Tcf1) is essential for several of these differentiation processes. Tcf1 is expressed in multiple isoforms, with all isoforms sharing the same HDAC and DNA-binding domains and the long isoforms containing a unique N-terminal β-catenin-interacting domain. In this study, we specifically ablated Tcf1 long isoforms in mice, while retaining expression of Tcf1 short isoforms. During CD8+ T cell responses, Tcf1 long isoforms were dispensable for generating cytotoxic CD8+ effector T cells and maintaining memory CD8+ T cell pool size, but they contributed to optimal maturation of central memory CD8+ T cells and their optimal secondary expansion in a recall response. In contrast, Tcf1 long isoforms were required for differentiation of T follicular helper (TFH) cells, but not TH1 effectors, elicited by viral infection. Although Tcf1 short isoforms adequately supported Bcl6 and ICOS expression in TFH cells, Tcf1 long isoforms remained important for suppressing the expression of Blimp1 and TH1-associated genes and for positively regulating Id3 to restrain germinal center TFH cell differentiation. Furthermore, formation of memory TH1 and memory TFH cells strongly depended on Tcf1 long isoforms. These data reveal that Tcf1 long and short isoforms have distinct, yet complementary, functions and may represent an evolutionarily conserved means to ensure proper programming of CD8+ and CD4+ T cell responses to viral infection.
Collapse
Affiliation(s)
- Jodi A Gullicksrud
- Department of Microbiology, University of Iowa, Iowa City, IA 52242.,Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA 52242
| | - Fengyin Li
- Department of Microbiology, University of Iowa, Iowa City, IA 52242
| | - Shaojun Xing
- Department of Microbiology, University of Iowa, Iowa City, IA 52242
| | - Zhouhao Zeng
- Department of Physics, The George Washington University, Washington, DC 20052; and
| | - Weiqun Peng
- Department of Physics, The George Washington University, Washington, DC 20052; and
| | - Vladimir P Badovinac
- Department of Microbiology, University of Iowa, Iowa City, IA 52242.,Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA 52242.,Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242
| | - John T Harty
- Department of Microbiology, University of Iowa, Iowa City, IA 52242.,Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA 52242
| | - Hai-Hui Xue
- Department of Microbiology, University of Iowa, Iowa City, IA 52242; .,Interdisciplinary Immunology Graduate Program, University of Iowa, Iowa City, IA 52242
| |
Collapse
|
103
|
Majchrzak K, Nelson MH, Bowers JS, Bailey SR, Wyatt MM, Wrangle JM, Rubinstein MP, Varela JC, Li Z, Himes RA, Chan SS, Paulos CM. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. JCI Insight 2017; 2:90547. [PMID: 28422756 PMCID: PMC5396523 DOI: 10.1172/jci.insight.90547] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2016] [Accepted: 03/14/2017] [Indexed: 12/30/2022] Open
Abstract
ICOS costimulation generates Th17 cells with durable memory responses to tumor. Herein, we found that ICOS induces PI3K/p110δ/Akt and Wnt/β-catenin pathways in Th17 cells. Coinhibiting PI3Kδ and β-catenin altered the biological fate of Th17 cells. Th17 cells inhibited of both pathways expressed less RORγt, which, in turn, reduced their ability to secrete IL-17. Unexpectedly, these cells were more effective (than uninhibited cells) at regressing tumor when infused into mice, leading to long-term curative responses. PI3Kδ inhibition expanded precursor Th17 cells with a central memory phenotype that expressed nominal regulatory properties (low FoxP3), while β-catenin inhibition enhanced Th17 multifunctionality in vivo. Remarkably, upon TCR restimulation, RORγt and IL-17 rebounded in Th17 cells treated with PI3Kδ and β-catenin inhibitors. Moreover, these cells regained β-catenin, Tcf7, and Akt expression, licensing them to secrete heightened IL-2, persist, and eradicate solid tumors without help from endogenous NK and CD8 T cells. This finding shines a light on ways to repurpose FDA-approved drugs to augment T cell-based cancer immunotherapies.
Collapse
Affiliation(s)
- Kinga Majchrzak
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Physiological Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| | - Michelle H. Nelson
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| | - Jacob S. Bowers
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| | - Stefanie R. Bailey
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| | - Megan M. Wyatt
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| | - John M. Wrangle
- Department of Hematology and Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Mark P. Rubinstein
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
| | - Juan C. Varela
- Department of Hematology and Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Zihai Li
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Richard A. Himes
- Department of Chemistry and Biochemistry, College of Charleston, Charleston, South Carolina, USA
- Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
- Neuroene Therapeutics, Mount Pleasant, South Carolina, USA
| | - Sherine S.L. Chan
- Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina, USA
- Neuroene Therapeutics, Mount Pleasant, South Carolina, USA
| | - Chrystal M. Paulos
- Department of Microbiology and Immunology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
- Department of Surgery
- Department of Dermatology and Dermatologic Surgery, and
| |
Collapse
|